Transaction
Helios Investment Partners exits T2S Group on the Casablanca Stock Exchange for MAD 1.1 billion
- Announced
- 27 July 2026
- Target
- T2S Group Holding SA
- Value
- $117.5m
- Asset class
- Private Equity
- Type
- Exit
- Instrument
- Ordinary Shares (Equity)
- Sector
- Healthcare / Medical Equipment, Pharmaceuticals, Digital Health Platforms
- Markets
- Morocco
- Post-money valuation
- $523.5m
About the target
T2S Group Holding SA is a Morocco-based holding company operating in the medical technology sector. The Company is organised into four operating subsidiaries: Techniques Science Santé, IM Alliance, Cyclopharma, and Binarios. Techniques Science Santé and IM Alliance distribute and maintain medical imaging, oncology, cardiology, and in vitro diagnostic equipment; Cyclopharma manufactures radiopharmaceutical contrast products; and Binarios develops hospital imaging and information software (PACS, RIS, HIS, LIS). Established in 1992 and headquartered in Casablanca, Morocco, the group serves public and private healthcare providers in Morocco and more than twenty other African countries, principally Francophone West and Central Africa. T2S Group Holding is listed on the Bourse de Casablanca under ticker T2S following its July 2026 initial public offering.
Sources
- www.heliosinvestment.com
- Partner Researchers